Jane Street Group, LLC Concert Pharmaceuticals, Inc. Transaction History

Jane Street Group, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$4.34 - $5.84 $82,425 - $110,913	18,992 Added 182.4%	29,404 $171,000
Q3 2022 Nov 14, 2022	BUY	$4.27 - $7.2 $44,459 - $74,966	10,412 New	10,412 $70,000
Q3 2022 Nov 14, 2022	BUY	$4.27 - $7.2 $44,459 - $74,966	10,412 New	10,412 $70,000
Q2 2022 Aug 16, 2022	SELL	$2.8 - $6.36 $46,555 - $105,747	-16,627 Closed	0 $0
Q1 2022 May 17, 2022	BUY	$2.73 - $3.94 $45,391 - $65,510	16,627 New	16,627 $56,000
Q3 2021 Nov 16, 2021	SELL	$3.17 - $4.15 $83,700 - $109,576	-26,404 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$3.77 - $5.24 $99,543 - $138,356	26,404 New	26,404 $111,000
Q4 2020 Feb 17, 2021	SELL	$9.48 - $12.84 $157,813 - $213,747	-16,647 Closed	0 $0
Q3 2020 Nov 17, 2020	BUY	$8.67 - $10.82 $144,329 - $180,120	16,647 New	16,647 $163,000
Q1 2018 May 15, 2018	SELL	$19.24 - $28.03 $335,180 - $488,310	-17,421 Closed	0 $0
Q4 2017 Feb 15, 2018	BUY	$13.96 - $29.05 $243,197 - $506,080	17,421	17,421 $451,000

Ticker CNCE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,934,600
Description
Concert Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that develops novel small molecule drugs for the treatment of autoimmune diseases. The company's lead product candidate is CTP-543, which is in Phase III clinical trial for the treatment of alopecia areata, a serious autoimmune dermatological condition. It has s...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.